|
|
| (11) | Number of the document | C 0966454 |
| (68) | Number of the document | 0966454 |
| (21) | Application number for Supplementary Protection Certificate | PA 2008 008 |
| (22) | Date of filing the application | 2008-05-09 |
| (41) | Date of publication of the application | 2008-06-25 |
| Date of publication of SPC | 2009-01-26 | |
| (24) | Date of coming into effect of SPC | 2018-02-17 |
| (71) |
Boehringer Ingelheim Pharma GmbH & Co.KG,
Binger Strasse 173, 55218 Ingelheim am Rhein,
DE
|
| (73) |
Boehringer Ingelheim Pharma GmbH & Co.KG,
Binger Strasse 173, 55218 Ingelheim am Rhein,
DE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (93) | EU/1/08/442/001-008, 2008-03-18 |
| (94) | 2023-02-17 |
| (95) | Dabigatranum etexilatum, mesylatum |
| Request filed | SPC extension granted until | Request refused | |
| 2021-02-04 | 2023-08-17 |
| Payment date | Validity (years) | Amount | |
| 2022-01-20 | 347.00 EUR |
| SPC expired |